GADD45a-GFP GreenScreen HC genotoxicity screening assay

Bibliography

• Ames B, McCann J, Yamasuki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutat Res 1975;31:347-64
   PubMed Web of Science ®Google Scholar
• Feinberg AP. Cancer epigenetics takes center stage. Proc Natl Acad Sci USA 2001;98:392-4
   PubMed Web of Science ®Google Scholar
• Snyder RD, Green JW. A review of the genotoxicity of marketed pharmaceuticals. Mutat Res 2001;88:151-69
   Google Scholar
• Physicians' Desk Reference, 55th edition. Montvale, NJ: Medical Economics Co. Inc.; 2001
   Google Scholar
• Kirkland D, Aardema M, Henderson L, Muller L. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat Res 2005;584:1-256
   PubMed Web of Science ®Google Scholar
• Kirkland D, Aardema M, Müller L, Hayashi M. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Mutat Res 2006;608:29-42
   PubMed Web of Science ®Google Scholar
• Matthews EJ, Kruhlak NL, Cimino MC, et al. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data. I. Identification of carcinogens using surrogate endpoints. Regul Toxicol Pharmacol 2006;44:83-96
   PubMed Web of Science ®Google Scholar
• US Federal Register. International Conference on Harmonisation: draft guidance on S2(R1) genotoxicity testing and data interpretation for pharmaceuticals intended for human use; availability. Available on: http://www.fda.gov/OHRMS/DOCKETS/98fr/08-1076.pdf 2008;73(59):16024-25
   Google Scholar
• Kirkland D, Pfuhler S, Tweats D, et al. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM Workshop. Mutat Res 2007;628:31-55
   PubMed Web of Science ®Google Scholar
• Thybaud V, Aardema M, Casciano D, et al. Relevance and follow-up of positive results in in vitro genetic toxicity assays: an ILSI-HESI initiative. Mutat Res 2007;633:67-79
   PubMed Web of Science ®Google Scholar
• Hastwell PW, Chai L, Roberts KJ, et al. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC Gadd45a-GFP genotoxicity assay. Mutat Res 2006;607:160-75
   PubMed Web of Science ®Google Scholar
• Newton R, Aardema M, Aubrecht J. The utility of DNA microarrays for characterizing genotoxicity. Environ Health Perspect 2004;112:420-2
   PubMed Web of Science ®Google Scholar
• Jacobson-Kram D, Contrera J. Genetic toxicity assessment: employing the best science for human safety evaluation. Part I. Early screening for potential human mutagens. Toxicol Sci 2007;96:16-20
   PubMed Web of Science ®Google Scholar
• Fornace AJ Jr, Jackman J, Hollander MC, et al. Genotoxic-stress-response genes and growth-arrest genes: Gadd, MyD and other genes induced by treatment eliciting growth arrest. Ann NY Acad Sci 1992;663:139-53
   PubMed Web of Science ®Google Scholar
• Hollander MC, Alamo I, Jackman J, et al. Analysis of the mammalian Gadd45 gene and its response to DNA damage. J Biol Chem 1993;268:24385-93
   PubMed Web of Science ®Google Scholar
• Nachman MW, Crowell SL. Estimate of the mutation rate per nucleotide in humans. Genetics 2000;156:297-304
   PubMed Web of Science ®Google Scholar
• Knight AW, Goddard NJ, Billinton N, et al. Fluorescence polarization discriminates green fluorescent protein from interfering autofluorescence in a microplate assay for genotoxicity. J Biochem Biophys Methods 2002;51:165-77
   PubMedGoogle Scholar
• Knight AW, Billinton N, Cahill PA, et al. An analysis of results from 305 compounds tested with the yeast RAD54-GFP genotoxicity assay (GreenScreen GC), including relative predictivity of regulatory tests and rodent carcinogenesis and performance with autofluorescent and coloured compounds. Mutagenesis 2007;22:409-16
   PubMed Web of Science ®Google Scholar
• Hartung T, Bremer S, Casati S, et al. A modular approach to the ECVAM principles on test validity. Altern Lab Anim 2004;32:467-72
   PubMed Web of Science ®Google Scholar
• Billinton N, Hastwell PW, Beerens D, et al. Interlaboratory assessment of the GreenScreen HC Gadd45a-GFP genotoxicity screening assay: an enabling study for independent validation as an alternative method. Mutat Res Genet Toxicol Environ Mutagen 2008; In press. Epub doi:10.1016/j.mrgentox.2008.02.011
   Google Scholar
• Gold LS. The carcinogenic potency project. 2007. Available from: http://potency.berkeley.edu/cpdb.html
   Google Scholar
• Gold LS, Slone TH, Manley NB, Ames BN. Misconceptions about the causes of cancer. Risk Controversy Series 3. Vancouver, BC: The Fraser Institute, Centre for Studies in Risk, Regulation and Environment; 2002
   Google Scholar
• Gold LS, David W, Gaylor DW, Slone TH. Comparison of cancer risk estimates based on a variety of risk assessment methodologies. Regul Toxicol Pharmacol 2003;37:45-53
   PubMed Web of Science ®Google Scholar
• Lave LB, Ennever FK, Rosenkranz HS, Omenn GS. Information value of the rodent bioassay. Nature 1988;336:631-3
   PubMed Web of Science ®Google Scholar
• Ashby J, Tinwell H. The rodent bone marrow micronucleus assay: contrast between its sensitiviy to human carcinogens and its sensitivity to NTP rodent carcinogens. Mutat Res 1996;352:181-4
   PubMed Web of Science ®Google Scholar
• Morita T, Asano N, Awogi T, et al. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (Groups 1, 2A and 2B): the summary report of the 6th collaborative study by CSGMT/JEMS. Mutat Res389:3-122
   PubMed Web of Science ®Google Scholar
• Tweats DJ, Blakey D, Heflich RH, et al. Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests. I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards. Mutat Res 2007;627:78-91
   PubMed Web of Science ®Google Scholar
• Jagger C, Tate M, Cahill P, et al. Genotoxicity assessment using a GADD45a-GFP reporter assay in a p53 competent human cell host: metabolic activation, flow cytometry and data update.Poster, Environmental Mutagen Society Annual Meeting; 2006
   Google Scholar
• Ku WW, Bigger A, Brambilla G, et al. Strategy for genotoxicity testing: metabolic considerations. Mutat Res 2007;627:59-77
   PubMed Web of Science ®Google Scholar
• Flückiger-Isler S, Baumeister M, Braun K, et al. Assessment of the performance of the Ames II™ assay: a collaborative study with 19 coded compounds. Mutat Res 2004;558:181-97
   PubMed Web of Science ®Google Scholar
• Reifferscheid G, Heil J, Oda Y, Zahn RK. A microplate version of the SOS/umu-test for rapid detection of genotoxins and genotoxic potentials of environmental samples. Mutat Res 1991;253:215-22
   PubMed Web of Science ®Google Scholar